Free Trial

Arrowstreet Capital Limited Partnership Takes Position in SNDL Inc. (NASDAQ:SNDL)

SNDL logo with Medical background
Remove Ads

Arrowstreet Capital Limited Partnership purchased a new stake in SNDL Inc. (NASDAQ:SNDL - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 1,248,922 shares of the company's stock, valued at approximately $2,236,000. Arrowstreet Capital Limited Partnership owned about 0.48% of SNDL as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently made changes to their positions in the company. State Street Corp lifted its stake in shares of SNDL by 1.5% in the third quarter. State Street Corp now owns 353,107 shares of the company's stock worth $727,000 after acquiring an additional 5,246 shares during the period. Newman Dignan & Sheerar Inc. grew its stake in shares of SNDL by 18.4% in the 4th quarter. Newman Dignan & Sheerar Inc. now owns 64,420 shares of the company's stock worth $115,000 after acquiring an additional 10,000 shares in the last quarter. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new position in shares of SNDL during the 4th quarter valued at approximately $25,000. EntryPoint Capital LLC purchased a new position in shares of SNDL in the fourth quarter worth about $32,000. Finally, SBI Securities Co. Ltd. bought a new stake in shares of SNDL during the fourth quarter valued at about $69,000.

SNDL Trading Down 3.3 %

Shares of NASDAQ:SNDL traded down $0.05 on Monday, hitting $1.32. The company had a trading volume of 1,192,973 shares, compared to its average volume of 2,631,497. The firm has a market capitalization of $345.55 million, a price-to-earnings ratio of -4.24 and a beta of 3.23. The firm's 50-day simple moving average is $1.59 and its two-hundred day simple moving average is $1.80. SNDL Inc. has a 1 year low of $1.26 and a 1 year high of $2.93. The company has a quick ratio of 4.16, a current ratio of 5.61 and a debt-to-equity ratio of 0.10.

Remove Ads

SNDL (NASDAQ:SNDL - Get Free Report) last announced its quarterly earnings results on Tuesday, March 18th. The company reported ($0.19) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.18). SNDL had a negative net margin of 12.11% and a negative return on equity of 8.27%. The firm had revenue of $179.06 million for the quarter, compared to the consensus estimate of $248.10 million. Equities analysts anticipate that SNDL Inc. will post -0.09 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Separately, ATB Capital raised their price target on SNDL from $3.50 to $4.00 in a research report on Wednesday, March 19th.

View Our Latest Report on SNDL

About SNDL

(Free Report)

SNDL Inc engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Liquor Retail, Cannabis Retail, Cannabis Operations, and Investments segments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use and medical markets; sells wines, beers, and spirits through wholly owned liquor stores; and private sale of recreational cannabis through wholly owned and franchised retail cannabis stores.

Read More

Institutional Ownership by Quarter for SNDL (NASDAQ:SNDL)

Should You Invest $1,000 in SNDL Right Now?

Before you consider SNDL, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SNDL wasn't on the list.

While SNDL currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Donald Trump Owns These 7 Stocks, Should You?

Donald Trump Owns These 7 Stocks, Should You?

He’s one of the most talked-about billionaires in the world—but when it comes to investing, Donald Trump’s stock picks are shockingly… low-key.

Related Videos

Donald Trump Owns These 7 Stocks, Should You?
 5 Stocks to BUY NOW in April 2025
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads